Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives
Dwan-Ying Chang,1 Wei-Li Ma,1,2 Yen-Shen Lu1 1Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; 2Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, TaiwanCorrespondence: Yen-Shen LuDepartment of Oncology, National Taiwan University Hosp...
Saved in:
Main Authors: | Chang DY (Author), Ma WL (Author), Lu YS (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of PIK3CA gene mutations in colorectal cancer and the selection of treatment strategies
by: Haitao Wang, et al.
Published: (2024) -
PIK3CA-Related Overgrowth Spectrum From Diagnosis to Targeted Therapy: A Case of CLOVES Syndrome Treated With Alpelisib
by: Angelica Pagliazzi, et al.
Published: (2021) -
Mutations of the PIK3CA gene in patients with breast cancer in the Krasnoyarsk region
by: A. V. Zyuzyukina, et al.
Published: (2024) -
Absence of PIK3CA mutation in primary mucinous ovarian carcinoma: An analysis of 20 Taiwanese cases by FemtoPath PIK3CA mutation screen kit
by: Wan-Ru Chao, et al.
Published: (2022) -
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
by: Qingfeng Huang, et al.
Published: (2022)